Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4192.0
(-2.58%)
JPY 4192.0
(-2.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.85 Billion JPY | 0.0% |
| 2022 | 3.85 Billion JPY | 0.0% |
| 2021 | 3.85 Billion JPY | 0.0% |
| 2020 | 3.85 Billion JPY | 0.0% |
| 2019 | 3.85 Billion JPY | -0.65% |
| 2018 | 3.87 Billion JPY | 0.0% |
| 2017 | 3.87 Billion JPY | 0.0% |
| 2016 | 3.87 Billion JPY | -22.61% |
| 2015 | 5 Billion JPY | -10.14% |
| 2014 | 5.57 Billion JPY | 28.12% |
| 2013 | 4.34 Billion JPY | -49.38% |
| 2012 | 8.59 Billion JPY | 0.56% |
| 2011 | 8.54 Billion JPY | -0.27% |
| 2010 | 8.56 Billion JPY | -0.84% |
| 2009 | 8.64 Billion JPY | 3.58% |
| 2008 | 8.34 Billion JPY | -4.2% |
| 2007 | 8.7 Billion JPY | -7.23% |
| 2006 | 9.38 Billion JPY | -49.58% |
| 2005 | 18.61 Billion JPY | -27.97% |
| 2004 | 25.84 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.85 Billion JPY | 0.0% |
| 2023 FY | 3.85 Billion JPY | 0.0% |
| 2023 Q2 | 3.85 Billion JPY | 0.0% |
| 2023 Q1 | 3.85 Billion JPY | 0.0% |
| 2023 Q4 | 3.85 Billion JPY | 0.0% |
| 2023 Q3 | 3.85 Billion JPY | 0.0% |
| 2022 Q3 | 3.85 Billion JPY | 0.0% |
| 2022 Q2 | 3.85 Billion JPY | 0.0% |
| 2022 Q1 | 3.85 Billion JPY | 0.0% |
| 2022 FY | 3.85 Billion JPY | 0.0% |
| 2022 Q4 | 3.85 Billion JPY | 0.0% |
| 2021 Q4 | 3.85 Billion JPY | 0.0% |
| 2021 Q2 | 3.85 Billion JPY | 0.0% |
| 2021 FY | 3.85 Billion JPY | 0.0% |
| 2021 Q1 | 3.85 Billion JPY | 0.0% |
| 2021 Q3 | 3.85 Billion JPY | 0.0% |
| 2020 Q3 | 3.85 Billion JPY | 0.0% |
| 2020 Q1 | 3.85 Billion JPY | 0.0% |
| 2020 Q2 | 3.85 Billion JPY | 0.0% |
| 2020 Q4 | 3.85 Billion JPY | 0.0% |
| 2020 FY | 3.85 Billion JPY | 0.0% |
| 2019 Q4 | 3.85 Billion JPY | -0.65% |
| 2019 FY | 3.85 Billion JPY | -0.65% |
| 2019 Q3 | 3.87 Billion JPY | 0.0% |
| 2019 Q1 | 3.87 Billion JPY | 0.0% |
| 2019 Q2 | 3.87 Billion JPY | 0.0% |
| 2018 Q3 | 3.87 Billion JPY | 0.0% |
| 2018 Q4 | 3.87 Billion JPY | 0.0% |
| 2018 Q2 | 3.87 Billion JPY | 0.0% |
| 2018 Q1 | 3.87 Billion JPY | 0.0% |
| 2018 FY | 3.87 Billion JPY | 0.0% |
| 2017 Q2 | 3.87 Billion JPY | 0.0% |
| 2017 FY | 3.87 Billion JPY | 0.0% |
| 2017 Q4 | 3.87 Billion JPY | 0.0% |
| 2017 Q3 | 3.87 Billion JPY | 0.0% |
| 2017 Q1 | 3.87 Billion JPY | 0.0% |
| 2016 Q1 | 3.87 Billion JPY | -22.61% |
| 2016 Q4 | 3.87 Billion JPY | 0.0% |
| 2016 Q3 | 3.87 Billion JPY | 0.0% |
| 2016 Q2 | 3.87 Billion JPY | 0.0% |
| 2016 FY | 3.87 Billion JPY | -22.61% |
| 2015 Q3 | 4.19 Billion JPY | 0.0% |
| 2015 Q1 | 4.19 Billion JPY | -24.71% |
| 2015 Q4 | 5 Billion JPY | 19.36% |
| 2015 FY | 5 Billion JPY | -10.14% |
| 2015 Q2 | 4.19 Billion JPY | 0.0% |
| 2014 Q1 | 4.19 Billion JPY | -3.54% |
| 2014 FY | 5.57 Billion JPY | 28.12% |
| 2014 Q4 | 5.57 Billion JPY | 32.82% |
| 2014 Q2 | 4.19 Billion JPY | 0.0% |
| 2014 Q3 | 4.19 Billion JPY | 0.0% |
| 2013 FY | 4.34 Billion JPY | -49.38% |
| 2013 Q4 | 4.34 Billion JPY | 3.06% |
| 2013 Q3 | 4.22 Billion JPY | 0.0% |
| 2013 Q2 | 4.22 Billion JPY | -49.7% |
| 2013 Q1 | 8.39 Billion JPY | -2.35% |
| 2012 Q3 | 8.39 Billion JPY | 0.0% |
| 2012 Q4 | 8.59 Billion JPY | 2.41% |
| 2012 FY | 8.59 Billion JPY | 0.56% |
| 2012 Q2 | 8.39 Billion JPY | 0.0% |
| 2012 Q1 | 8.39 Billion JPY | -1.8% |
| 2011 Q3 | 8.39 Billion JPY | 0.0% |
| 2011 Q1 | 8.39 Billion JPY | -2.07% |
| 2011 Q2 | 8.39 Billion JPY | 0.0% |
| 2011 Q4 | 8.54 Billion JPY | 1.84% |
| 2011 FY | 8.54 Billion JPY | -0.27% |
| 2010 Q1 | 8.51 Billion JPY | -1.5% |
| 2010 Q2 | 8.51 Billion JPY | 0.0% |
| 2010 FY | 8.56 Billion JPY | -0.84% |
| 2010 Q3 | 8.39 Billion JPY | -1.41% |
| 2010 Q4 | 8.56 Billion JPY | 2.11% |
| 2009 FY | 8.64 Billion JPY | 3.58% |
| 2009 Q3 | 8.51 Billion JPY | 0.0% |
| 2009 Q4 | 8.64 Billion JPY | 1.53% |
| 2009 Q2 | 8.51 Billion JPY | 0.0% |
| 2008 Q4 | 8.34 Billion JPY | 15.69% |
| 2008 FY | 8.34 Billion JPY | -4.2% |
| 2008 Q3 | 7.21 Billion JPY | 0.0% |
| 2007 FY | 8.7 Billion JPY | -7.23% |
| 2006 FY | 9.38 Billion JPY | -49.58% |
| 2005 FY | 18.61 Billion JPY | -27.97% |
| 2004 FY | 25.84 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 77.207% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.921% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 99.081% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | 66.867% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -3729.741% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -34.053% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 98.138% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -805.882% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -83.333% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -943.36% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 69.737% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 77.328% |
| Tsumura & Co. | 79.69 Billion JPY | 95.169% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -122.93% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -1477.869% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 98.097% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 86.7% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 91.909% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 81.619% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -1.076% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | 55.844% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -6316.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -833.333% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | 59.41% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 95.355% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -321.687% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 87.27% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -36.269% |